Page last updated: 2024-12-07

dimyristoylphosphatidylglycerol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Dimyristoylphosphatidylglycerol (DMPG) is a synthetic phospholipid that is commonly used as a model membrane component in biophysical studies. It is composed of two myristoyl fatty acid chains, a glycerol backbone, and a phosphate group linked to a glycerophosphate head group. DMPG is a major component of the inner membrane of bacteria and chloroplasts, where it plays a role in maintaining membrane stability and fluidity. It is also involved in the regulation of membrane protein function and in the transport of ions across membranes. Research on DMPG is important for understanding the structure and function of biological membranes, as well as for developing new drug delivery systems and therapeutic agents.'

Cross-References

ID SourceID
PubMed CID107767
SCHEMBL ID12312159
MeSH IDM0043503

Synonyms (28)

Synonym
dmpg
14:0 pg
dimyristoylphosphatidylglycerol
61361-72-6
3-{[(2,3-dihydroxypropoxy)(hydroxy)phosphoryl]oxy}-2-(tetradecanoyloxy)propyl tetradecanoate
[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-tetradecanoyloxypropyl] tetradecanoate
tetradecanoic acid, 1-((((2,3-dihydroxypropoxy)hydroxyphosphinyl)oxy)methyl)-1,2-ethanediyl ester
bi71wt9p3r ,
dimyristoylphosphatidylglycerol, dl-
unii-bi71wt9p3r
alf component dmpg
alfq component dmpg
dmpg, (+/-)-
1,2-dimyristoyl-glycero-3-(phospho-rac-(1-glycerol))
tetradecanoic acid, 1,1'-(1-((((2,3-dihydroxypropoxy)hydroxyphosphinyl)oxy)methyl)-1,2-ethanediyl) ester
army liposome formulation component dmpg
dmpg, dl-
1,2-dimyristoyl-glycero-3-phospho-(1'-rac-glycerol)
SCHEMBL12312159
BPHQZTVXXXJVHI-UHFFFAOYSA-N
DB11284
DTXSID80976890
Q27274677
dl-dimyristoylphosphatidylglycerol
3-(((2,3-dihydroxypropoxy)(hydroxy)phosphoryl)oxy)propane-1,2-diyl ditetradecanoate
[2,3-bis(tetradecanoyloxy)propoxy](2,3-dihydroxypropoxy)phosphinic acid
EN300-33419802
pg 14:0_14:0

Research Excerpts

Effects

ExcerptReferenceRelevance
"Dimyristoylphosphatidylglycerol (DMPG) has been extensively studied as a model for biological membranes, since phosphatidylglycerol is the most abundant anionic phospholipid in prokaryotic cells. "( Thermal transitions of DMPG bilayers in aqueous solution: SAXS structural studies.
Amaral, LQ; Lamy-Freund, MT; Riske, KA, 2001
)
1.75

Toxicity

ExcerptReferenceRelevance
" Diacyl-TAP was less toxic than SA, and DPPC was less toxic than DMPC."( Multivariate toxicity screening of liposomal formulations on a human buccal cell line.
Jacobsen, J; Sande, SA; Smistad, G, 2007
)
0.34
"Curcumin is a multi-functional and pharmacologically safe natural agent."( An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells.
Burke, TG; Chen, C; Gedaly, R; Jeon, H; Johnston, TD; McHugh, PP; Ranjan, D, 2009
)
0.35

Compound-Compound Interactions

ExcerptReferenceRelevance
" The aim of the present study was to improve the dissolution rate and hence the oral bioavailability of a poorly water soluble imidazole antifungal model drug, ketoconazole (KET), via the preparation of SDs using phospholipid carriers either alone or in combination with other hydrophilic carriers."( Potential use of phospholipids in combination with hydrophilic carriers for enhancement of the dissolution and oral bioavailability of imidazole antifungal Class II drugs.
Abu Hashim, II; El-Shabouri, MH; Ghazy, NF, 2015
)
0.42

Bioavailability

ExcerptReferenceRelevance
" In spite of its safety and efficacy, the in vivo bioavailability of curcumin is poor, and this may be a major obstacle to its utility as a therapeutic agent."( An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells.
Burke, TG; Chen, C; Gedaly, R; Jeon, H; Johnston, TD; McHugh, PP; Ranjan, D, 2009
)
0.35
" A small amount of carrier phospholipid significantly increases the rate and the extent of dissolution, which may increase the bioavailability of ibuprofen."( Ibuprofen-phospholipid solid dispersions: improved dissolution and gastric tolerance.
Brausch, JF; Hussain, MD; Saxena, V; Talukder, RM, 2012
)
0.38
" Membrane mimetic models were used to evaluate the RFB2's membrane partition, its preferential location across the membrane, and the effect of RFB2 on the biophysical properties of the membrane, which ultimately might be related with the antimycobacterial compound bioavailability and the membrane toxicity."( Drug-membrane interaction studies applied to N'-acetyl-rifabutin.
Arêde, M; Caio, JM; Lúcio, M; Moiteiro, C; Pinheiro, M; Reis, S, 2013
)
0.39
" The aim of the present study was to improve the dissolution rate and hence the oral bioavailability of a poorly water soluble imidazole antifungal model drug, ketoconazole (KET), via the preparation of SDs using phospholipid carriers either alone or in combination with other hydrophilic carriers."( Potential use of phospholipids in combination with hydrophilic carriers for enhancement of the dissolution and oral bioavailability of imidazole antifungal Class II drugs.
Abu Hashim, II; El-Shabouri, MH; Ghazy, NF, 2015
)
0.42
" Moreover, bioavailability of DTX from BI-CHI-DTX-NC was increased by 10-folds with longer circulation time and slower plasma elimination with low tissue distribution as compared to DTX solution."( Development of novel biotinylated chitosan-decorated docetaxel-loaded nanocochleates for breast cancer targeting.
Ahiwale, R; Bothiraja, C; Mahadik, K; Pawar, A; Poudel, I, 2018
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (437)

TimeframeStudies, This Drug (%)All Drugs %
pre-199036 (8.24)18.7374
1990's118 (27.00)18.2507
2000's137 (31.35)29.6817
2010's133 (30.43)24.3611
2020's13 (2.97)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.58

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.58 (24.57)
Research Supply Index6.11 (2.92)
Research Growth Index4.90 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.58)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.22%)5.53%
Reviews2 (0.45%)6.00%
Case Studies1 (0.22%)4.05%
Observational0 (0.00%)0.25%
Other444 (99.11%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]